MX2011009256A - Emulsiones aceite-en-agua anionicas conteniendo prostaglandinas y usos de las mismas. - Google Patents

Emulsiones aceite-en-agua anionicas conteniendo prostaglandinas y usos de las mismas.

Info

Publication number
MX2011009256A
MX2011009256A MX2011009256A MX2011009256A MX2011009256A MX 2011009256 A MX2011009256 A MX 2011009256A MX 2011009256 A MX2011009256 A MX 2011009256A MX 2011009256 A MX2011009256 A MX 2011009256A MX 2011009256 A MX2011009256 A MX 2011009256A
Authority
MX
Mexico
Prior art keywords
anionic oil
oil
water emulsions
emulsions containing
water
Prior art date
Application number
MX2011009256A
Other languages
English (en)
Inventor
Betty Philips
Frederic Lallemand
Jean-Sebastien Garrigue
Original Assignee
Novagali Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novagali Pharma Sa filed Critical Novagali Pharma Sa
Publication of MX2011009256A publication Critical patent/MX2011009256A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Materials For Medical Uses (AREA)

Abstract

La presente invención se refiere a una emulsión aniónica aceite- en-agua coloidal que comprende una prostaglandina, un aceite teniendo un valor de yodo = 2, un surfactante y agua, siempre que la emulsión aniónica aceite-en-agua no contenga alcohol polivinílico. La presente invención también pertenece al uso de dichas emulsiones aniónicas aceite-en-agua para intensificar la estabilidad de dichas prostaglandinas, para el tratamiento e hipertensión ocular y/o glaucoma, para promover el crecimiento de pestañas y/o para tratar hipotricosis de pestañas.
MX2011009256A 2009-03-04 2010-03-04 Emulsiones aceite-en-agua anionicas conteniendo prostaglandinas y usos de las mismas. MX2011009256A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15734709P 2009-03-04 2009-03-04
EP09305203A EP2228058A1 (en) 2009-03-04 2009-03-04 Anionic oil-in-water emulsion containing prostaglandins and uses thereof
PCT/EP2010/052740 WO2010100217A1 (en) 2009-03-04 2010-03-04 Anionic oil-in-water emulsions containing prostaglandins and uses thereof

Publications (1)

Publication Number Publication Date
MX2011009256A true MX2011009256A (es) 2011-09-27

Family

ID=40626733

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011009256A MX2011009256A (es) 2009-03-04 2010-03-04 Emulsiones aceite-en-agua anionicas conteniendo prostaglandinas y usos de las mismas.

Country Status (12)

Country Link
US (1) US9089480B2 (es)
EP (2) EP2228058A1 (es)
JP (1) JP5722802B2 (es)
KR (2) KR101879381B1 (es)
CN (1) CN102341093B (es)
AU (1) AU2010220321B2 (es)
CA (1) CA2754156C (es)
ES (1) ES2572373T3 (es)
HK (1) HK1166608A1 (es)
IL (1) IL214506A (es)
MX (1) MX2011009256A (es)
WO (1) WO2010100217A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2314354T3 (es) * 2004-11-09 2009-03-16 Novagali Pharma S.A. Emulsion de tipo aceite en agua con baja concentracion de agente cationico y potencial zeta positivo.
US7666912B2 (en) 2006-03-23 2010-02-23 Massachusetts Eye And Ear Infirmary Compositions and methods for reducing body fat
EP2389939A1 (en) 2010-05-28 2011-11-30 Novagali Pharma S.A. Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
WO2012038469A2 (en) * 2010-09-21 2012-03-29 S&V Technologies Ag Cosmetic composition
US9089579B2 (en) 2011-01-19 2015-07-28 Topokine Therapeutics, Inc. Methods and compositions for treating metabolic syndrome
US8426471B1 (en) 2011-12-19 2013-04-23 Topokine Therapeutics, Inc. Methods and compositions for reducing body fat and adipocytes
US20140322428A1 (en) 2013-03-15 2014-10-30 Leading Edge Innovations, LLC Compositions having an oil-in-water dispersion of submicron particles to enhance foods and beverages
NO2753788T3 (es) * 2013-05-10 2018-06-16
WO2014186504A1 (en) 2013-05-15 2014-11-20 Topokine Therapeutics, Inc. Methods and compositions for topical delivery of prostaglandins to subcutaneous fat
WO2015200425A1 (en) 2014-06-27 2015-12-30 Topokine Therapeutics, Inc. Topical dosage regimen
PL427837A1 (pl) * 2018-11-22 2020-06-01 Gbj Pharma Spółka Z Ograniczoną Odpowiedzialnością Systemy do ciągłego obwodowego podawania latanoprostu dla obniżania ciśnienia śródgałkowego
CN111840225B (zh) * 2020-08-12 2021-09-14 陈丽娜 一种用于治疗青光眼的滴眼剂及其制备方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599353A (en) 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
JPH0818989B2 (ja) 1984-01-12 1996-02-28 株式会社ミドリ十字 脂肪乳剤中のプロスタグランジンの安定化方法
JP2602964B2 (ja) 1989-10-16 1997-04-23 裕 水島 プロスタグランジン類縁体およびその脂肪乳剤
IL101241A (en) 1992-03-16 1997-11-20 Yissum Res Dev Co Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier
US5688819A (en) 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
EP0631770B1 (en) 1993-06-25 1998-07-22 Alcon Cusi, S.A. New use of polymeric membranes in the dispensing of pharmaceutical solutions that contain quaternary ammonium compounds as preservatives and corresponding dose dispensor
ES2094688B1 (es) 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
US5631287A (en) 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US6011062A (en) * 1994-12-22 2000-01-04 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US6066671A (en) 1997-12-19 2000-05-23 Alcon Laboratories, Inc. Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides
FR2823441B1 (fr) 2001-04-12 2004-09-10 Thea Lab Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation
EP1418903A2 (en) 2001-04-23 2004-05-19 The Board of Regents of the University of Texas System Prostanoids augment ocular drug penetration
JP2005513097A (ja) 2001-11-01 2005-05-12 イサム・リサーチ・デベロツプメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシテイ・オブ・エルサレム ドライアイ治療方法および組成物
KR100446960B1 (ko) 2001-12-04 2004-09-01 김종국 프로스타글란딘 ｅ1을 포함하는 온도감응성 에멀젼 외용제조성물
US20050124699A1 (en) 2002-07-02 2005-06-09 Wakamoto Pharmaceutical Co., Ltd. Drugs for treating or preventing disorders of corneal and/or conjunctival epithelial cells
CN100361661C (zh) 2002-08-23 2008-01-16 参天制药株式会社 以拉坦前列素为有效成分的稳定的滴眼液
CA2707067C (en) 2002-09-09 2013-07-16 Santen Pharmaceutical Co., Ltd. Clear ophthalmic solution comprising latanoprost as active ingredient
US20040115234A1 (en) 2002-09-24 2004-06-17 Gewirtz Joan T. Cosmetic composition
US7074827B2 (en) 2002-10-24 2006-07-11 Sucampo Ag (Usa) Inc. Method for treating ocular hypertension and glaucoma
ATE442146T1 (de) 2003-11-07 2009-09-15 Senju Pharma Co Pharmazeutische zusammensetzung mit prostaglandin
ES2314354T3 (es) 2004-11-09 2009-03-16 Novagali Pharma S.A. Emulsion de tipo aceite en agua con baja concentracion de agente cationico y potencial zeta positivo.
AU2005304034B2 (en) 2004-11-09 2012-02-16 Santen Sas Ophthalmic emulsions containing an immunosuppressive agent
ES2351358T3 (es) * 2005-10-10 2011-02-03 Novagali Pharma S.A. Emulsiones oftálmicas que contienen prostaglandinas.
TWI376239B (en) * 2006-02-01 2012-11-11 Andrew Xian Chen Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
WO2007105691A1 (ja) 2006-03-13 2007-09-20 R-Tech Ueno, Ltd. 水性組成物
WO2008035246A2 (en) 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions containing quaternary ammonium compounds
TWI394564B (zh) 2006-09-21 2013-05-01 Alcon Res Ltd 自行保存型水性藥學組成物
CN101516332B (zh) 2006-09-21 2012-12-19 爱尔康研究有限公司 自身防腐的水性药物组合物
CA2672973C (en) * 2006-12-21 2016-03-08 Novagali Pharma Sa Process for manufacturing ophthalmic oil-in-water emulsions
US20080234376A1 (en) * 2007-03-21 2008-09-25 Taiwan Liposome Company (A Taiwan Corporation) Emulsion composition comprising prostaglandin e1
EP1985298A1 (en) * 2007-04-24 2008-10-29 Azad Pharma AG Ophtalmic oil-in-water emulsions containing prostaglandins
JP2011521957A (ja) 2008-05-28 2011-07-28 アルコン リサーチ， リミテッド 自己防腐エマルジョン
EP2127638A1 (en) 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
EP2228057A1 (en) 2009-03-04 2010-09-15 Novagali Pharma S.A. Cationic oil-in-water emulsions containing prostaglandins and uses thereof
EP2389939A1 (en) 2010-05-28 2011-11-30 Novagali Pharma S.A. Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions

Also Published As

Publication number Publication date
EP2403478B1 (en) 2016-03-02
KR20170052695A (ko) 2017-05-12
US20110319488A1 (en) 2011-12-29
KR20120003856A (ko) 2012-01-11
CN102341093A (zh) 2012-02-01
CA2754156C (en) 2017-06-06
IL214506A0 (en) 2011-09-27
KR101786760B1 (ko) 2017-10-18
AU2010220321B2 (en) 2015-08-20
US9089480B2 (en) 2015-07-28
JP2012519664A (ja) 2012-08-30
CN102341093B (zh) 2014-08-27
CA2754156A1 (en) 2010-09-10
EP2403478A1 (en) 2012-01-11
IL214506A (en) 2016-08-31
ES2572373T3 (es) 2016-05-31
WO2010100217A1 (en) 2010-09-10
HK1166608A1 (en) 2012-11-02
EP2228058A1 (en) 2010-09-15
JP5722802B2 (ja) 2015-05-27
KR101879381B1 (ko) 2018-08-16
AU2010220321A1 (en) 2011-09-01

Similar Documents

Publication Publication Date Title
MX2011009256A (es) Emulsiones aceite-en-agua anionicas conteniendo prostaglandinas y usos de las mismas.
WO2010111267A3 (en) Personal-care composition comprising a cationic active
EP4302734A3 (en) Ocular delivery systems and methods
WO2013178683A3 (de) N-methyl-n-acylglucamin enthaltende zusammensetzung
PH12019501902A1 (en) Ocular formulations for drug-delivery to the posterior segment of the eye
NI201400010A (es) Cosmético
FR2938437B1 (fr) Utilisation cosmetique de microorganisme pour le traitement des peaux grasses
EA201301102A1 (ru) Композиция для регуляции роста растений
WO2013130948A3 (en) Sunscreen composition comprising uv composite
WO2012016000A3 (en) Preservative free brimonidine and timolol solutions
MX2011009258A (es) Emulsiones aceite-en-agua cationicas conteniendo prostaglandinas y usos de las mismas.
ECSP11011395A (es) Emulsiones nutritivas con un contenido elevado de fibras
WO2012015998A3 (en) Preservative free bimatoprost and timolol solutions
PH12016500647B1 (en) Antiperspirant emulsion sticks
WO2014097258A3 (en) Aqueous cosmetic composition comprising alkylcellulose
WO2009101323A3 (fr) Composition cosmétique sous forme d'émulsion huile-dans-eau comprenant un tensioactif cationique de type ester ammonium quaternaire dérivé de 2-[2-(diéthylamino)éthoxy]éthanol
ZA202108950B (en) Oxymetazoline compositions and methods for treating ocular disorders
IN2014CN04809A (es)
EA201301332A1 (ru) ОФТАЛЬМОЛОГИЧЕСКИЙ ПРЕПАРАТ, СОДЕРЖАЩИЙ АНАЛОГ PGF2α
MX337016B (es) Fijacion de perfume sobre piel humeda.
PH12016501901A1 (en) Composition in the form of an oil-in-water emulsion comprising ground white or yellow mustard seed
RU2011152889A (ru) Косметическая композиция для ухода за кожей на основе эмульсии "масло в воде"
EA201692234A1 (ru) Композиция в форме эмульсии "масло-в-воде", содержащая молотое семя белой или желтой горчицы
PH12019502608A1 (en) Nanoemulsions with color stabilized actives
EA201991379A1 (ru) Новые наноэмульсии, содержащие глицерин в водной фазе

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status

Owner name: BASF SE